Bears mauling this drug maker's shares
Bears mauled the drug maker, unloading shares and snapping up puts, after management failed to address concerns about major patent expirations beginning in 2011.
Drug stocks climbed Thursday as shares of Cerus rocketed on a positive study for its blood-platelet treatment system Intercept.